Collagen supplements are widely marketed for smoother, more hydrated, more elastic skin. The research on this question is more nuanced than most advertising suggests. Here is a plain, honest look at what the evidence currently shows — and where it falls short.
What the research looked at
Several meta-analyses have pooled data from randomized controlled trials — the type of study considered most reliable for testing whether a treatment actually works — to ask whether taking oral collagen peptides changes measurable skin qualities. The outcomes of interest were mainly skin hydration and skin elasticity, tracked over trial periods of roughly 8 to 12 weeks, which is the typical window used in this line of research.
What it found
Taken at face value, the pooled trials suggest that oral collagen peptides may produce a modest improvement in skin hydration and elasticity over that 8-to-12-week window. But looking more closely changes the picture considerably. When researchers separated out higher-quality studies — those with stronger methods and less risk of bias — the apparent benefits often shrank or disappeared entirely. The same pattern showed up when studies funded by supplement manufacturers were compared with independently funded studies: benefits were smaller, or not there, in the studies without industry funding. On top of that, some of the reported gains in wrinkles or skin density appeared to be driven less by a genuine, consistent effect and more by statistical outliers and by differences between individual studies (in their design, populations, or measurement methods) than by collagen itself.
What it means (and the limits)
Put together, this is a mixed picture, not a clear-cut one. Some trials do report benefits for skin hydration and elasticity, but the size of that benefit is moderate at best, and it tends to weaken under closer scrutiny — particularly when a study is better designed or has no financial stake in a positive result. That combination of factors is exactly why collagen should not be presented as a proven anti-aging treatment. It may have a modest supporting role for skin hydration and elasticity in some people, but the current evidence does not support strong claims about wrinkles, skin density, or dramatic visible aging reversal. As with joint-health research on collagen, benefits reported for skin appear gradual and modest rather than dramatic, and no supplement is a cure. Anyone considering collagen for skin or any other reason should treat it as one modest factor among many — alongside sun protection, hydration, and overall skin care — and discuss it with a doctor or pharmacist if they have specific concerns.
Sources: https://www.amjmed.com/article/S0002-9343(25)00283-9/abstract · https://pubmed.ncbi.nlm.nih.gov/33742704/
Dual-action joint collagen
Mafsal Riyadi combines the two collagen types most studied for joints — high-tripeptide hydrolyzed collagen and undenatured type II collagen — in one licensed dietary supplement (EDA reg. no. 14711/2026). Research about ingredient categories is general and is not a claim about any individual product.
Learn about Mafsal RiyadiThis is a plain-language summary of published research for general education. It is not medical advice, a diagnosis, or a treatment recommendation, and individual studies have limitations. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult your doctor or pharmacist about your own situation.
